Dear Doctor: Is the new flu vaccine better enough to justify waiting for it?
The US has seen the launch of Moderna's mFlusiva, the first approved mRNA flu vaccine designed for specific older adult populations.
7 trends tracked about this subject — the full history, oldest to newest below.
The US has seen the launch of Moderna's mFlusiva, the first approved mRNA flu vaccine designed for specific older adult populations.
A newly approved mRNA flu shot for adults 50+ is rolling out at CVS, Walgreens and local pharmacies as the 2026 flu season approaches.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
A breakthrough pancreatic cancer drug wins FDA approval and hits the clinic, raising questions over patient access.
8 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
After two decades of stagnation, the FDA has approved a new sunscreen ingredient—one already widely used abroad.